Vanguard Personalized Indexing Management LLC lifted its stake in Tellurian Inc. (NYSEAMERICAN:TELL – Free Report) by 88.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 60,204 shares of the oil and gas producer’s stock after acquiring an additional 28,236 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in Tellurian were worth $42,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors also recently made changes to their positions in the company. BNP Paribas Financial Markets lifted its holdings in Tellurian by 22.9% in the 1st quarter. BNP Paribas Financial Markets now owns 1,785,943 shares of the oil and gas producer’s stock valued at $1,181,000 after acquiring an additional 333,362 shares during the last quarter. Rafferty Asset Management LLC raised its holdings in shares of Tellurian by 124.5% in the 4th quarter. Rafferty Asset Management LLC now owns 2,910,652 shares of the oil and gas producer’s stock worth $2,199,000 after purchasing an additional 1,614,230 shares in the last quarter. Swiss National Bank lifted its stake in Tellurian by 13.8% during the first quarter. Swiss National Bank now owns 1,326,400 shares of the oil and gas producer’s stock valued at $877,000 after purchasing an additional 160,900 shares during the last quarter. Vanguard Group Inc. boosted its holdings in Tellurian by 12.5% during the first quarter. Vanguard Group Inc. now owns 37,380,931 shares of the oil and gas producer’s stock worth $24,724,000 after buying an additional 4,149,531 shares in the last quarter. Finally, Moloney Securities Asset Management LLC acquired a new position in Tellurian in the first quarter worth approximately $99,000. 48.87% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Separately, B. Riley reaffirmed a “neutral” rating and set a $1.00 target price (down previously from $2.50) on shares of Tellurian in a research note on Monday, July 22nd.
Insider Transactions at Tellurian
In other news, Director Diana Derycz Kessler sold 1,000,000 shares of Tellurian stock in a transaction on Wednesday, July 24th. The shares were sold at an average price of $0.95, for a total transaction of $950,000.00. Following the transaction, the director now directly owns 1,050,000 shares of the company’s stock, valued at $997,500. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. 3.00% of the stock is owned by corporate insiders.
Tellurian Stock Performance
NYSEAMERICAN:TELL opened at $0.97 on Wednesday. The company has a market capitalization of $867.29 million, a PE ratio of -3.23 and a beta of 2.56. The company has a quick ratio of 0.27, a current ratio of 0.27 and a debt-to-equity ratio of 0.38. Tellurian Inc. has a 1 year low of $0.36 and a 1 year high of $1.16. The firm has a 50 day moving average price of $0.71.
Tellurian (NYSEAMERICAN:TELL – Get Free Report) last announced its earnings results on Thursday, August 8th. The oil and gas producer reported ($0.04) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.04). Tellurian had a negative net margin of 129.88% and a negative return on equity of 20.24%. As a group, analysts forecast that Tellurian Inc. will post -0.19 EPS for the current fiscal year.
Tellurian Profile
Tellurian Inc engages in the natural gas business worldwide. It operates through three segments: The Upstream, The Midstream, and The Marketing & Trading. The company produces, gathers, purchases, sells, and delivers natural gas; acquires and develops natural gas assets; and develops, constructs, and operates liquefied natural gas terminals and pipelines.
Further Reading
- Five stocks we like better than Tellurian
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Why Lennar Stock Could Be the Best Play in the Housing Market
- What is a Stock Market Index and How Do You Use Them?
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Dividend Capture Strategy: What You Need to Know
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Tellurian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tellurian and related companies with MarketBeat.com's FREE daily email newsletter.